Combination therapeutics of Nilotinib and radiation in Acute Lymphoblastic Leukemia as an effective method against drug resistance
2016-08
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Combination therapeutics of Nilotinib and radiation in Acute Lymphoblastic Leukemia as an effective method against drug resistance
Authors
Published Date
2016-08
Publisher
Type
Thesis or Dissertation
Abstract
In this work we combine in vitro experimentation with mathematical modeling to study the combined effect of the tyrosine kinase inhibitor nilotinib and ionizing radiation on acute lymphoblastic leukemia cells. We develop a mathematical model for the cell response to this combined therapy. This mathematical model is parameterized via cell viability experiments conducted at a variety of different levels of nilotinib concentration and radiation exposure. We use this parameterized mathematical model to predict cell viability at new levels of nilotinib concentration. These predictions are then compared with new sets of cell viability experiments. We then investigate the structure of optimal radiation dosing schedules under our mathematical model. Finally, the model is expanded to incorporate an additional toxicity constraint on healthy lymphoblast cells, further characterizing optimized treatment protocols.
Keywords
Description
University of Minnesota M.S. thesis. August 2016. Major: Biomedical Informatics and Computational Biology. Advisor: Jasmine Foo. 1 computer file (PDF); vi, 49 pages.
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Penning, Jackson. (2016). Combination therapeutics of Nilotinib and radiation in Acute Lymphoblastic Leukemia as an effective method against drug resistance. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/182153.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.